Latest Healthcare News

Charter Hall Long WALE REIT reported a 128% surge in statutory profit to $275.9 million for FY26, supported by a $150.7 million property revaluation gain and a $248 million net acquisition spree. The REIT also completed a $2 billion debt refinancing, extending maturities and cutting margins.

Bailador Technology Investments (ASX:BTI) posted a 64% drop in net profit to $6.9 million for FY26, amid a 55% fall in gains on financial assets. Despite this, the fund declared a fully franked 3.5 cent dividend and highlighted strong AI adoption and growth across its private tech portfolio.

Vital Healthcare Property Trust (NZX:VHP) delivered a robust FY26, marked by a successful management internalisation, 23.5% AFFO growth, and a stable distribution payout, underpinning its position as a leading healthcare infrastructure owner in Australasia.

Pro Medicus’ US subsidiary Visage Imaging has landed a 7-year, A$23 million contract to deploy its cloud-based Visage 7 platform across St. Luke’s Health System, marking a further expansion in North America.

Anteris Technologies posted a $51.7 million loss in H1 2026 amid ramped-up R&D and clinical trial activity, supported by a $320 million capital raise and Medicare reimbursement for its DurAVR heart valve trial.

EBR Systems marked a commercial milestone with over 100 WiSE CRT implants and secured purchasing agreements with three major US healthcare networks. The company is progressing toward Medicare coverage and scaling manufacturing, supported by a near-complete A$150 million capital raise.

PM Capital Global Opportunities Fund (ASX: PGF) is raising up to $195 million through a $175 million placement and a $20 million share purchase plan at $3.07 per share, matching its net tangible asset value and offering a fully franked 7.5 cent dividend for 2026.

LTR Pharma reports a 93% response rate in men seeking convenience and spontaneity with SPONTAN, alongside a 64% response in post-prostatectomy patients, highlighting potential for its rapid-onset intranasal ED treatment in challenging populations.

ReNerve Limited has gained marketing approval for its flagship NervAlign Nerve Cuff in India, marking a critical milestone in its global expansion and enabling commercial rollout in one of the world's largest nerve repair markets.

PM Capital Global Opportunities Fund Limited delivered a 41.5% jump in profit after tax to $238 million for FY26 and raised its fully franked dividend guidance to 16 cents for FY27, reflecting strong portfolio returns and robust earnings reserves.

Integral Diagnostics (ASX: IDX) posted strong preliminary FY26 results with revenue nearing $790 million and operating EBITDA up 30%, while announcing Jenny Martin as incoming CFO amid leadership transitions.

Austco Healthcare is acquiring Medical Communications Systems to deepen its direct sales footprint in South Australia, continuing a string of reseller takeovers that bolster its market presence and earnings.